SLC2A1 and hepatocellular carcinoma: In this study, we found BMP type I receptor (BMP I) inhibitor LDN193189 and SLC2A1 inhibitor BAY-876 can effectively inhibit glycogenesis and glycogenolysis genes in HCC cells, suggesting that BMP4 plays a regulatory role through SMAD signaling pathway.